State Street
TNXP icon

State Street’s Tonix Pharmaceuticals TNXP Stock Holding History

State Street’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.17M Buy
230,607
+38,752
+20% +$597K ﹤0.01% 3145
2025
Q4 		$3M Buy
191,855
+39,311
+26% +$725K ﹤0.01% 3202
2025
Q3 		$3.69M Buy
152,544
+29,287
+24% +$1.09M ﹤0.01% 3111
2025
Q2 		$4.43M Buy
123,257
+103,204
+515% +$2.7M ﹤0.01% 2999
2025
Q1 		$358K Buy
20,053
+19,722
+5,958% +$400K ﹤0.01% 3680
2024
Q4 		$10.9K Buy
+331
New +$6.88K ﹤0.01% 4275
2024
Q2 		– Sell
-10
Closed -$5.8K – 4396
2024
Q1 		$5.8K Hold
10
– – ﹤0.01% 4349
2023
Q4 		$12.6K Hold
10
– – ﹤0.01% 4383
2023
Q3 		$17K Hold
10
– – ﹤0.01% 4461
2023
Q2 		$49.3K Hold
10
– – ﹤0.01% 4421
2023
Q1 		$115K Buy
10
+8
+400% +$137K ﹤0.01% 4277
2022
Q4 		$18.6K Hold
2
– – ﹤0.01% 4741
2022
Q3 		$25K Hold
2
– – ﹤0.01% 4793
2022
Q2 		$75K Sell
2
-10
-83% -$738K ﹤0.01% 4625
2022
Q1 		$1.71M Buy
12
+2
+20% +$306K ﹤0.01% 3626
2021
Q4 		$2.39M Hold
10
– – ﹤0.01% 3584
2021
Q3 		$3.99M Buy
10
+2
+25% +$974K ﹤0.01% 3349
2021
Q2 		$5.66M Buy
+8
New +$5.88M ﹤0.01% 3188
2021
Q1 		– Hold
0
– – – 3903
2017
Q1 		– Hold
0
– -$7K – 3672
2016
Q4 		– Hold
0
– – – 3653
2016
Q3 		– Hold
0
– – – 3576
2016
Q2 		– Hold
0
– – – 3626
2016
Q1 		– Hold
0
– – – 3630

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street's TNXP Position: Q1 2026 in Review

State Street increased its Tonix Pharmaceuticals (TNXP) stake by 20% in Q1 2026, buying an estimated $597K and bringing the position to 230,607 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3145.

State Street first reported a position in TNXP in Q2 2021 and has held it in 18 quarters since. The position peaked at $5.66M in Q2 2021. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • State Street held 230,607 shares of Tonix Pharmaceuticals worth $3.17M as of Q1 2026.
  • State Street bought 38,752 Tonix Pharmaceuticals shares in Q1 2026, an estimated $597K.
  • Tonix Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3145 holding.
  • State Street first reported a position in Tonix Pharmaceuticals in Q2 2021 and has held it in 18 quarters since.
  • State Street's Tonix Pharmaceuticals position peaked at $5.66M in Q2 2021.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.